Tirzepatide, una nuova frontiera nel trattamento dell’obesità

World Obesity Federation (2022) World obesity atlas 2022. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2022

Wilding JPH, Batterham RL, Calanna S et al. (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384:989–1002

Frìas JP, Davies MJ, Rosenstock J et al. (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med 385(6):503–515